Omada Health (OMDA) EBITDA (2024 - 2026)

Omada Health has disclosed EBITDA across 3 years of filings, most recently posting $3.5 million for Q2 2026.

• In Q2 2026, EBITDA rose 181.7% year-over-year to $3.5 million; the TTM figure through Jun 2026 stood at -$464000.0 (up 98.36% YoY), while the FY2025 annual figure was -$12.0 million, up 72.58% from the prior year.
• EBITDA came in at $3.5 million for Q2 2026 at Omada Health, up from -$4.8 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $3.5 million in Q2 2026 to a low of -$10.0 million in Q2 2024.
• Average EBITDA over 3 years is -$4.3 million, with a median of -$4.8 million recorded in 2026.
• The largest YoY upside for EBITDA was 181.7% in 2026 against a maximum downside of 43.06% in 2026.
• Over 3 years, EBITDA stood at -$7.1 million in 2024, then soared by 146.21% to $3.3 million in 2025, then rose by 8.17% to $3.5 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $3.5 million in Q2 2026, -$4.8 million in Q1 2026, and $3.3 million in Q4 2025.